Review decisions
Showing 900 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00854
Product Type: Drug
Control Number: 253630
Manufacturer: SaNOtize Research & Development Corp.
Submission Type: Application for authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2021-06-11
Decision / Authorization Date: 2021-09-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00844
Product Type: Drug
Control Number: 253430
DIN(s): 02510014
Manufacturer: ModernaTX, Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2021-06-04
Decision / Authorization Date: 2021-08-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00581
Product Type: Drug
Control Number: 255370
DIN(s): 02525364
Manufacturer: Novavax Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-08-27
Issued / Original Publication Date: 2022-04-08
Decision / Authorization Date: 2022-02-17
Updated Date: 2024-07-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00272
Issued / Original Publication Date: 2021-08-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00613
Product Type: Drug
Control Number: 256188
DIN(s): 02529548, 02529556
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-27
Issued / Original Publication Date: 2022-11-21
Decision / Authorization Date: 2022-07-28
Updated Date: 2025-06-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00631
Product Type: Drug
Control Number: 256191
DIN(s): 02532530, 02532581
Manufacturer: AbbVie Corporation
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-27
Issued / Original Publication Date: 2023-03-30
Decision / Authorization Date: 2022-11-10
Updated Date: 2026-01-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00970
Product Type: Drug
Control Number: 247481
DIN(s): 02519364
Manufacturer: Vertex Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2021-08-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1691500592141
Product Type: Drug
Control Number: 255507
DIN(s): 02537435, 02537443
Manufacturer: Idorsia Pharmaceuticals Ltd
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-25
Issued / Original Publication Date: 2023-08-04
Decision / Authorization Date: 2023-04-28
Updated Date: 2025-10-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01075
Product Type: Drug
Control Number: 248423
DIN(s): 02519380
Manufacturer: Pendopharm, Division of Pharmascience Inc.
Submission Type: New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-01-15
Decision / Authorization Date: 2021-08-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00602
Product Type: Drug
Control Number: 255972
DIN(s): 02527391, 02527405
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2021-08-20
Issued / Original Publication Date: 2022-08-30
Decision / Authorization Date: 2022-05-26
Updated Date: 2026-02-02